Call for Abstracts: Track 03 – Cancer


17th International Conference on Pathology, Digital Pathology & Cancer | February 01–02, 2027 | Dubai & Virtual

Cancer remains one of the most pressing global health challenges, driving continuous innovation in diagnosis, treatment, and research. In response to this growing need for collaboration and advancement, the Utilitarian Conferences Gathering proudly invites researchers, clinicians, academicians, and healthcare professionals to contribute to Track 03: Cancer at the 17th International Conference on Pathology, Digital Pathology & Cancer, scheduled for February 01–02, 2027, at Novotel Al Barsha, Dubai, UAE, with virtual participation options available.

This international conference serves as a dynamic platform to bring together global experts and emerging researchers to exchange knowledge, present innovative research, and discuss the latest developments in cancer science and pathology.


The Importance of Cancer Research

Cancer research is at the forefront of modern medicine, with ongoing efforts focused on early detection, targeted therapies, and personalized treatment approaches. Advances in molecular biology, genomics, and immunotherapy have significantly improved patient outcomes, yet challenges such as late diagnosis, treatment resistance, and disease recurrence persist.

The integration of digital pathology and artificial intelligence is further transforming oncology by enabling precise tumor characterization, predictive analytics, and improved clinical decision-making. Collaborative platforms like this conference are essential to accelerate breakthroughs and translate research into real-world clinical applications.


About the Conference

The 17th International Conference on Pathology, Digital Pathology & Cancer is designed to foster innovation, collaboration, and professional growth. The conference will feature:

  • Distinguished keynote speakers from leading global institutions

  • Scientific sessions highlighting cutting-edge research

  • Panel discussions on current challenges and future directions

  • Poster and oral presentation opportunities

  • Industry exhibitions showcasing advanced technologies

Attendees will gain valuable insights into the latest trends and innovations in cancer research and pathology.


Track 03: Cancer

We invite original research abstracts, case studies, and reviews that contribute to the advancement of cancer research and clinical practice. Topics of interest include, but are not limited to:

  • Cancer Biology and Tumor Microenvironment

  • Oncology and Clinical Cancer Research

  • Cancer Genomics and Molecular Oncology

  • Immunotherapy and Targeted Therapies

  • Early Detection and Cancer Screening

  • Biomarkers and Personalized Medicine

  • Translational Cancer Research

  • Advances in Cancer Diagnostics and Imaging

  • Digital Pathology in Oncology

  • AI Applications in Cancer Diagnosis

Submissions should demonstrate scientific rigor, innovation, and relevance to current challenges in oncology.


Important Deadline

Abstract Submission Deadline: 15 May 2026

Participants are encouraged to submit their abstracts as early as possible to ensure consideration for presentation. Early submissions may also benefit from preferred session placement.


Submission Process

Authors can submit their abstracts through the official conference submission portal. Ensure your submission clearly outlines the research objectives, methodology, key findings, and significance of the study.

Accepted abstracts will be selected for oral or poster presentations, offering authors a valuable opportunity to present their work on an international stage.


Benefits of Participation

Participating in this conference provides numerous professional advantages:

  • International Exposure: Showcase your research to a global audience

  • Networking Opportunities: Connect with experts, researchers, and industry leaders

  • Professional Development: Enhance your academic and clinical profile

  • Knowledge Exchange: Stay updated with the latest advancements in cancer research

  • Collaboration Opportunities: Build partnerships for future research initiatives

All presenters will receive official certification recognizing their contribution.


Hybrid Participation Model

The conference offers both in-person and virtual participation options, ensuring accessibility for global participants. Whether attending onsite in Dubai or joining remotely, participants will have full access to scientific sessions and networking opportunities.


Venue Highlight

The in-person event will take place at Novotel Al Barsha, Dubai, a modern venue equipped with state-of-the-art facilities. Dubai’s reputation as a global hub for innovation and healthcare makes it an ideal location for hosting an international scientific conference.


Get Involved Today

Cancer research continues to evolve rapidly, and your contribution can play a vital role in shaping the future of oncology. This conference provides a unique opportunity to share your work, learn from global experts, and be part of meaningful scientific discussions.

Submit your abstract/paper:  https://pathology.utilitarianconferences.com/submit-abstract

Connect via WhatsApp:  https://wa.me/+971551792927


#CancerResearch #Oncology #CancerAwareness #CancerScience #TumorBiology #CancerGenomics #MolecularOncology #Immunotherapy #CancerImmunology #TargetedTherapy #PrecisionOncology #CancerDiagnostics #OncoPathology #CancerBiomarkers #TranslationalOncology #ClinicalOncology #BreastCancerResearch #LungCancerResearch #CancerPrevention #EarlyCancerDetection #PersonalizedCancerTreatment #CancerInnovation #OncologyResearch #GlobalOncology #FutureOfCancerCare #AIinOncology #DigitalOncology #CancerTechnology #HealthcareInnovation #NextGenOncology


Comments

Popular posts from this blog

Join Us at the 15th Emirates Pathology, Digital Pathology & Cancer Conference – Dubai & Virtual | September 02–04, 2025

How Digital Pathology is Accelerating Research and Drug Development

The Role of Molecular Pathology in Infectious Disease Detection